Latest Cystic Fibrosis Foundation Stories
BOULDER, Colo., Dec. 22, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
BOULDER, Colo., Nov. 19, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
Funds will be used to expand cystic fibrosis research, care and patient programs BETHESDA, Md., Nov.
Largest pharmaceutical royalty purchase ever completed NEW YORK, Nov.
NIH Awards Two Grants to Academic Partners to Progress Mucolytic Research Program DURHAM, N.C., Oct.
SAN DIEGO, Oct.
Collaborative Forum to Focus on Promising Advances in Drug Development, Research and Care for People with CF ATLANTA, Oct.
ChanTest’s expertise will be showcased at the North American Cystic Fibrosis Conference this month, highlighting the important research the company has conducted to help move cystic fibrosis
Expanded Collaboration Supports Phase 2 Clinical Trial Initiation of First-In-Class ENaC Inhibitor for the Treatment of Cystic Fibrosis DURHAM, N.C., Sept.
Cystic Fibrosis Foundation - Greater Illinois Chapter wins August's Community Assistance Program LINCOLNWOOD, Ill., Sept.
- Having no light.
- Of or relating to the region of a body of water that is not reached by sunlight and in which photosynthesis is unable to occur.